Norma O’Donovan

Epidermal growth factor receptor as a potential therapeutic target in triple-negative breast cancer

B. Corkery, John Crown, Martin Clynes et al. · Annals of Oncology · 2009 · 337 citations · Full text

Potential Therapeutic Target, Breast Oncology, Medicine +7

Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib

Neil A. O’Brien, Brigid C. Browne, Lucy Chow et al. · Molecular Cancer Therapeutics · 2010 · 334 citations

Radiation Oncology, Breast Oncology, Signal Transduction +11

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Michael J. Duffy, Maeve Mullooly, Norma O’Donovan et al. · Clinical Proteomics · 2011 · 200 citations · Full text

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

Alexandra Canonici, Merel Gijsen, Maeve Mullooly et al. · Oncotarget · 2013 · 162 citations · Full text

Trastuzumab Resistance, Breast Oncology, Trastuzumab-sensitive Breast Cancer +13

Caspase 3 in breast cancer.

Norma O’Donovan, John Crown, Helen Stunell et al. · PubMed · 2003 · 146 citations